Home/Filings/4/0001209191-23-014626
4//SEC Filing

Oakes Gregory 4

Accession 0001209191-23-014626

CIK 0001785345other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:13 PM ET

Size

5.6 KB

Accession

0001209191-23-014626

Insider Transaction Report

Form 4
Period: 2023-02-28
Oakes Gregory
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-02-28+475,300475,300 total
    Exercise: $0.37Exp: 2033-02-27Common Stock (475,300 underlying)
Footnotes (1)
  • [F1]1/4th of the shares initially subject to the option shall vest on the one (1) year anniversary of the date of grant (such anniversary being the "Anniversary Date") and 1/48th of the shares initially subject to the option shall vest on each monthly anniversary of the Anniversary Date thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.

Issuer

Landos Biopharma, Inc.

CIK 0001785345

Entity typeother

Related Parties

1
  • filerCIK 0001809796

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:13 PM ET
Size
5.6 KB